These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28070878)

  • 1. Effects of Caffeic Acid and Quercetin on In Vitro Permeability, Metabolism and In Vivo Pharmacokinetics of Melatonin in Rats: Potential for Herb-Drug Interaction.
    Jana S; Rastogi H
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):781-791. PubMed ID: 28070878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
    Rastogi H; Jana S
    Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ziziphus jujuba fruit extracts on cytochrome P450 (CYP1A2) activity in rats.
    Jing XY; Peng YR; Wang XM; Duan JA
    Chin J Nat Med; 2015 Aug; 13(8):588-94. PubMed ID: 26253491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
    Vaghela M; Sahu N; Kharkar P; Pandita N
    Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
    Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
    Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats.
    Zhang YH; Zhang YJ; Guo YL; Li WJ; Yu C
    J Pharm Pharmacol; 2013 Jan; 65(1):149-55. PubMed ID: 23215698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
    Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
    Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assessment of CYP1A2 and 2C9 inhibition potential of Withania somnifera and Centella asiatica in human liver microsomes.
    Savai J; Varghese A; Pandita N; Chintamaneni M
    Drug Metab Pers Ther; 2015 Jun; 30(2):137-41. PubMed ID: 25938222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo.
    Kim SB; Kim KS; Ryu HM; Hong SH; Kim BK; Kim DD; Park JW; Yoon IS
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
    Wang B; Yang S; Hu J; Li Y
    J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats.
    Gao N; Qi B; Liu FJ; Fang Y; Zhou J; Jia LJ; Qiao HL
    PLoS One; 2014; 9(2):e89752. PubMed ID: 24587011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo.
    Jiang B; Meng L; Zhang F; Jin X; Zhang G
    Life Sci; 2017 Nov; 189():1-7. PubMed ID: 28893642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
    Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
    J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies.
    Cao L; Kwara A; Greenblatt DJ
    J Pharm Pharmacol; 2017 Dec; 69(12):1762-1772. PubMed ID: 28872689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro phase I cytochrome P450 metabolism, permeability and pharmacokinetics of SB639, a novel histone deacetylase inhibitor in preclinical species.
    Venkatesh PR; Goh E; Zeng P; New LS; Xin L; Pasha MK; Sangthongpitag K; Yeo P; Kantharaj E
    Biol Pharm Bull; 2007 May; 30(5):1021-4. PubMed ID: 17473456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats.
    Zhu Q; Liao J; Xie L; Wang GJ; Liu XD
    Xenobiotica; 2009 Apr; 39(4):293-301. PubMed ID: 19350452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats.
    Xu RA; Xu ZS; Ge RS
    J Ethnopharmacol; 2014 Feb; 151(3):1141-1146. PubMed ID: 24373810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro and in-vivo evaluations of cytochrome P450 1A2 interactions with nuciferine.
    Hu L; Xu W; Zhang X; Su J; Liu X; Li H; Zhang W
    J Pharm Pharmacol; 2010 May; 62(5):658-62. PubMed ID: 20609070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats.
    Zhao Q; Wei J; Zhang H
    Xenobiotica; 2019 May; 49(5):563-568. PubMed ID: 29768080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.